Patent Ductus Arteriosus – How Relevant are Biomarkers for the Diagnosis?

被引：0
作者：
P Koehne
机构：
[1] Charité-University,
[2] Campus Virchow Hospital,undefined
[3] Dept. of Neonatology,undefined
来源：
Pediatric Research | 2011年 / 70卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
In contrast to clinical signs echocardiography allows us to identify a PDA early and to monitor treatment. Nevertheless, despite several echocardiographic parameters of proved accuracy a “gold standard” for judgement of the haemodynamic severity of a PDA that targets treatment more effectively has not been established. Therefore, during daily routine most neonatologists look at more than one criteria before making the decision to treat a PDA, but again the chosen combination of parameters might not be evidence based.
引用
收藏
页码：56 / 56
相关论文
共 24 条
[1]  
Choi BM(2005)Utility of rapid B-type natriuretic peptide assay for diagnosis of symptomatic patent ductus arteriosus in preterm infants Pediatrics 115 e255-61
[2]  
Lee KH(2005)The use of a bedside assay for plasma B-type natriuretic peptide as a biomarker in the management of patent ductus arteriosus in premature neonates J Pediatr 147 38-42
[3]  
Eun BL(2008)B-type natriuretic peptide to predict ductus intervention in infants <28 weeks Pediatr Res 64 286-90
[4]  
Flynn PA(2008)N-terminal pro-B-type natriuretic peptide: a measure of significant patent ductus arteriosus Arch Dis Child Fetal Neonatal Ed 93 F257-60
[5]  
da Graca RL(2009)N-terminal probrain natriuretic peptide and patent ductus arteriosus in preterm infants J Perinatol 29 137-42
[6]  
Auld PA(2008)Influence of a patent ductus arteriosus on cardiac troponin T levels in preterm infants J Pediatr 153 350-3
[7]  
Nesin M(undefined)undefined undefined undefined undefined-undefined
[8]  
Kleinman CS(undefined)undefined undefined undefined undefined-undefined
[9]  
Czernik C(undefined)undefined undefined undefined undefined-undefined
[10]  
Lemmer J(undefined)undefined undefined undefined undefined-undefined
123